AIM: To evaluate whether a dedicated epilepsy research protocol with expert image reevaluation can increase identification of patients with lesions and to attempt to ascertain the potential reasons why lesions were not identified previously on earlier clinical magnetic resonance imaging (MRI).
Introduction
The detection of a brain abnormality on magnetic resonance imaging (MRI) 1e4 in addition to concordant focal electroencephalogram (EEG) spike discharges 5e7 has been related to good surgical outcomes, while patients with no remarkable MRI findings are rendered seizure-free less often. 7e9 Unfortunately, it is not uncommon for patients with severe seizure activity to present with an unremarkable MRI; however, it is likely that (subtle) epileptogenic lesions are not detected on routine clinical MRI and contribute to ongoing seizure activity. It is important that (1) the MRI protocol and (2) subsequent qualitative and quantitative assessment of the images is specifically tailored for patients with epilepsy so that potentially small lesions causing debilitating seizures can be detected and treated. Several publications to date have discussed the factors that can increase the accuracy of lesion detection through MRI in clinical practice. 10e13 In one study, outcome after surgery improved significantly with the introduction of an epilepsy-dedicated MRI protocol, which increased the sensitivity of epilepsy-related lesion detection (e.g., hippocampal sclerosis, HS) rather than applying a standardised MRI protocol. 11 Nevertheless, the authors state that even with a dedicated protocol, optimisation of acquisition parameters (e.g., angulation according to the presumed seizure onset zone) may be necessary for individual patients. 11 Overall, when correlating radiological findings with histopathology, neuropathological diagnoses were predicted correctly in 89% of epilepsy-dedicated MRI reports, but only by 22% of "non-expert" reports (MRI assessed by radiologists not attached to epilepsy centres) based on standard MRI. 11 Consequently, an early referral to a specialist epilepsy centre may increase the lesion detection rate. Hardware may also play a role; Phal et al. 14 and Winston et al. 15 reported an up to 30% increase in diagnostic yield of 3 T images versus 1.5 T. These results indicate that higher signal-to-noise ratio (SNR) facilitates the detection of focal epileptogenic lesions. The aim of the present study was to evaluate whether an epilepsy-dedicated research protocol with expert image reevaluation could increase identification of patients with lesions. This required patients to have no discernible brain abnormality based on a previous clinical MRI (not part of an epilepsy-dedicated research protocol). This earlier MRI was included in an evaluation of lesion conspicuity to qualitatively re-evaluate factors likely to have contributed to the new presentation of a lesion. Considering the previous reports of increased diagnostic yield using 3 T as opposed to 1.5 T MRI 14, 15 and the application of epilepsy-dedicated MRI protocols, 11 the objective of this work was to determine whether the use of a dedicated epilepsy research protocol in a specialist hospital of neurology and neurosurgery would benefit lesion conspicuity and identification. Importantly, MRI could be assessed to illustrate if MRI hardware, image signal decay due to artefacts (e.g. head motion), radiological expertise or the protocol had an influence on the individual diagnosis at the time. Failure to identify lesions earlier may have multiple reasons and may be directly linked to lesion conspicuity. The work conducted here may provide important clinical information on the number of patients who have epileptogenic lesions but have unremarkable MRI by virtue of previous imaging protocols not specialised for the detection of epileptogenic lesions. Identification of an underlying brain abnormality can potentially afford important implications for treatment consequences, such as earlier referral for epilepsy surgery for patients with medically refractory focal epilepsies. According to Wiebe and Jette, 16 surgery is effective but underused. In particular, it has been shown to be costeffective, 17 to save lives, 18 and improve quality of life by reducing seizure frequency. 19 Consequently, epilepsy surgery with appropriate presurgical evaluation may afford many advantages over the continued use of anti-epileptic drugs (AED).
Materials and methods
The study was approved by the local ethical board for the application of MRI scanning and collection of previous clinical data in patients with refractory focal epilepsy. The epilepsy-dedicated research protocol was conducted between November 2014 and April 2016. All participants provided written informed consent. A 3 Tesla General Electric Discovery MR750 scanner (Waukesha, WI, USA) with a 32-channel head coil was used for prospective acquisition of MRI images. Forty-three patients (26 female; mean age AE standard deviation [SD] ¼ 31.6AE11, range 18e61) with focal refractory epilepsy who had failed at least two trials of AED treatments were studied. Patients were neuroradiologists. This included data from patients acquired on 1.5 and 3 T systems, with and without dedicated clinical epilepsy protocols. The previous clinical MRI images were re-evaluated in order to determine the factors influencing the accuracy of visual lesion detection. Two neuroradiologists with long-term experience in evaluating MRI of patients with epilepsy performed reassessment of the images independently from one another. Demographic and clinical information for all patients are summarised in Table 1 .
Results
Twenty-nine of the 43 (67%) patients remained MRI negative after assessment of the epilepsy-dedicated MRI by the consultant neuroradiologists; however, 14/43 (33%) patients were found to have potentially epileptogenic brain lesions, such as HS and focal cortical dysplasia (FCD), shown in Fig 1. Diagnostic information for these patients is presented in Table 2 .
All available images are presented in the results sections along with clinically relevant information for each patient. Eleven of the 14 (79%) previously "non-lesional" patients had EEG imaging-concordant localisation features (except for patients 59, 65, and 84) rendering them potential candidates for resective surgery. Surgical candidacy had been assessed during the multidisciplinary team meetings that consider results from MRI, neurophysiological, and neuropsychological evaluation. For eight of the 14 patients (57%) previous MRI examinations (from the authors' centre and another) were available for retrospective evaluation. The remaining images could not be retrieved as they had been acquired at other hospitals. This section initially presents the eight cases with a new identifiable lesion for whom previous MRI studies were available (Figs 2e9). Subsequently, the remaining six cases for whom previous MRI was not obtainable are presented (Fig 10) . The reasons for lesions not being reported in this dataset were multifactorial and were due to the following factors (Table 3) : (1) general technical issues affecting image quality and lesion conspicuity: (i) low SNR (Fig 2) and movement artefacts (Fig 3) have contributed to loss of lesion conspicuity on the T2-FLAIR images. Consequently, the lesion was not identified as HS ( Figs 2 and 3) ; (ii) the previous MRI, which was not part of a dedicated epilepsy research protocol, had technical issues, and therefore, did (ii) the standard MRI was reviewed and reported as "nonlesional" by a general radiologist, although the lesion was visible (Fig 7) ; (iii) loss of information during communication: the neuroradiologist referred to the abnormality without stating "hippocampal sclerosis", and subsequently, the information was documented inappropriately (Figs 3 and 4) . Rather, the hippocampi for these patients were referred to as "small", e.g., "small appearance of the left hippocampus" (patient 24) and "bilateral small hippocampi" (patient 25). In-vivo MRI is the most reliable and frequent imaging method used to provide information on macroscopic brain structure, and in the presence of varying data quality, it is often impossible for neuroradiologists to evaluate the definite presence of lesions. The lesion that most frequently escaped the attention of clinicians was HS (nine cases, of which two had an additional FCD), followed by FCDs (two cases), and others including gliosis, encephalocoele, and amygdala enlargement (one case each).
The previous images for patients 27 , 51, 59, 69, 81, and 84 could not be retrieved. All lesions reported for these patients were conspicuous on the most recent images acquired using the dedicated epilepsy research protocol (Fig 10) . So far, five patients (patient 22 with right HS; 38 with left HS; 56 with right HS; 66 with left HS; 81 with left HS) have received ipsilateral temporal lobectomies. All resected specimens had histological confirmation of HS. 20 These patients have been followed up at various time points after surgery (2 years, 2 years, 1 year, 3 months, and 1 week, respectively) and classified according to the International League Against Epilepsy (ILAE) outcome classifications. 21 Patients 22, 56, 66, and 81 are currently seizure free (ILAE I). Patient 38 no longer experiences secondary generalised toniceclonic seizures (SGTCS), and now experiences one short (<10 seconds) focal seizure per week, which represents a substantial improvement (ILAE III). Three other patients (51, 59, and 61) are still being considered for surgery.
Discussion
The objective of the present study was to employ an epilepsy-dedicated MRI protocol in a cohort of patients with refractory focal epilepsy who were deemed previously to be non-lesional on clinical MRI. Thirty-three percent of all patients recruited had a newly identified brain lesion. The primary factors explaining the newly identified lesions were the choice of MRI sequences, imaging parameters (in particular, no previous use of a dedicated epilepsy research protocol, including the lack of angulation orthogonal to the long axis of the hippocampus and large section thickness), data quality (motion artefacts and low SNR), human factors (lesion not reported), and loss of information through incomplete documentation (wording: "small hippocampus" instead of "hippocampal sclerosis").
The results presented here indicate that one important factor why lesions had previously escaped the attention of the reporting neuroradiologist may be the choice of sequence with lesions being more conspicuous on dedicated epilepsy protocols.
10e13 According to Duncan et al.
2016
, 12 Duncan 1997 22 and ILAE 1997, 10 3D whole-brain T1W and T2W and 2D FLAIR imaging should be included in an effective epilepsy-dedicated protocol. Additionally, apart from the specific choice of the sequence itself, lesion conspicuity may be influenced by data quality, section thickness, angulation, and resolution. Expert neuroradiologist reassessment using epilepsy-dedicated MRI can detect HS with sensitivity and specificity of >90%. 11,23 Two images not routinely acquired in the evaluation of patients with epilepsy at the authors' centre proved useful for the detection of FCDs/gliosis (3D T2-FLAIR) and encephalocoeles (3D T2W). Tschampa et al. 24 indicated previously that 2D/3D T2-FLAIR sequences are equally useful for detecting FCDs visually, while Friedman 13 stated that the whole-brain coronal 3D T2W sequence can be helpful in detecting encephalocoele and may be superior over T1W sequences. 25 Encephalocoeles may be an under-appreciated aetiology of temporal lobe epilepsy. 26 Additionally, an isotropic voxel size may increase the diagnostic yield as it can cover multiple locations within the brain and may identify small lesions, such as encephalocoeles or gliosis. It has been previously reported that image artefacts, such as subject motion, can affect lesion conspicuity. 14 As a rule, when patients moved excessively during the recently applied epilepsy research dedicated protocol, MRI was reacquired in order to avoid motion artefacts. High lesion conspicuity on good-quality MRI is the core characteristic for the neuroradiologist to be able to confidently report an abnormality. For patients who remain "non-lesional", it may be apt to also acquire 3D T2-FLAIR and 3D T2W data as these sequences can increase the lesion pick-up-rate, are easily implemented, and can be performed at low cost concerning acquisition times. As a direct result of this translational study using research-dedicated MRI, clinicians at The Walton Centre NHS Foundation Trust have now started to request 3D T2-FLAIR images for patients with refractory focal epilepsy and previous inconclusive MRI. Regarding human factors, the lesion most frequently left unreported was HS (nine cases), which was also reported in a previous study. 11 These authors reported that HS was overlooked in 86% of cases when the MRI was read by general radiologists relative to expert neuroradiologists. In this sample, FCDs accounted for the second most frequent lesions left unreported (four cases). These results correspond to those found by Stevens 27 where routine MRI failed to show HS in all cases and FCDs in 20% of all cases. Multiple sites of gliosis and a single unilateral amygdala enlargement were identified in two different patients on their most recent epilepsy-dedicated research MRI conducted in the context of this study. Unfortunately, the previous MRI was not available in these cases. Zubkov et al. 28 described a patient with a hypothalamic hamartoma (HH) who did not benefit from right temporal lobectomy as his HH (possibly also involved in the epileptogenic network) was overlooked. He then had the HH removed and consequently suffered severe memory problems (amnesia). This case illustrates the need to assess for dual (or even multiple) pathology in treatment of pharmacoresistant epilepsy prior to surgery. The review presented here has shown several patients with multiple lesion sites; therefore, it is important that neuroradiologists are aware of the satisfaction-of-search effect 29 and continue radiological assessment even when epilepsyrelated lesions have already been identified. Importantly, based on the present results, a differential checklist has been devised for radiologists when assessing the presence Figure 10 Formerly 'non-lesional' cases showing lesions using the epilepsy dedicated research protocol. Numbers refer to patient IDs. Please refer to Table 2 for details on each lesion identified. R ¼ right.
of a lesion: (1) medial temporal lobe on coronal T1-FLAIR/ T2-FLAIR (especially for patients with complex partial seizures) to investigate for HS; (2) cortical thickening and blurring of greyewhite matter margin on T1W image for FCD; (3) floor of the middle cranial fossa on T2W images for encephalocoeles; and (4) subtle cortical and subcortical white matter hyperintensity on T2-FLAIR image for gliosis. Another important point relates to the communication between neuroradiologists and clinicians. A recent study on patients with frontotemporal dementia has found that diagnostic information may be reported inappropriately (with a limited factual description and incomplete misleading interpretation of MRI) unless MRI images are jointly reviewed and discussed by neurologists and neuroradiologists. 30 In the present study, the apparent hesitation in officially diagnosing hippocampal volume loss on MRI as HS has resulted in two patients being misclassified as nonlesional. Therefore, clinicians may benefit from an equidistant rating scale where it is possible for the neuroradiologist to indicate how confident they are in reporting an abnormality and to state reasons for why their confidence is very high/high/medium/low or very low (e.g., due to slice angulation/motion artefacts). A similar rating scale has been used by some centres to record the degree of atrophy in patients, 30e32 the likelihood of presence of FCD 33 and artefacts. 14 A confidence rating scale may facilitate reacquisition with appropriate and individualised sequence parameters if necessary, but certainly this should be subject to further research. Even though the true-positive rate of 33% within this investigation of a realistic clinical setting is large and potentially clinically significant for individual patients, one limitation remains the fact that results are based on a small sample size. Another limitation of this dataset is that it does not allow the direct comparison of individual sequence acquisition parameters or of MRI hardware. The type of MRI sequences and the data quality varied for all initial clinical MRI studies, which were not part of the more recently applied epilepsy-dedicated protocol and acquired at different time points. As in the example of an initial negative report based on MRI with poor quality and lesion conspicuity, the lesion may not have been appreciated due to artefacts, human factors or both (i.e., retrospectively the lesion is discernible on the initial MRI even when taking the artefacts into account). This also reflected the opinion of the consultant neurologist and neuroradiologists who retrospectively re-evaluated the initial MRI images: in almost all cases the reasons for leaving an abnormality unreported remain multifactorial. Consequently, this made it difficult to attribute a single reason to leaving a lesion unreported. A prospective study where MRI is evaluated by an expert neuroradiologist in a blinded fashion (e.g., one with motion artefacts, one without in the same patient, etc.) may resolve some of these open questions. Nevertheless, this retrospective study of previous MRI in a realistic clinical setting was capable of shedding light on the factors that may influence everyday clinical practice. An acknowledgement of these being multifactorial may facilitate a deeper understanding and re-evaluation of current MRI protocols, neuroradiological assessment, and communication between clinicians.
In conclusion, it is important for all clinicians to undertake detailed assessment of MRI images and discuss difficult patient cases in MDT meetings. Ultimately, consideration of all the interdependent factors mentioned in this review have important implications for (i) treatment options for the individual patient, especially regarding epilepsy surgery performed on newly identified epileptogenic lesions; and (ii) study populations that may have been confounded by undetected lesions in patient samples if sequences were not dedicated to depicting epilepsy lesions and MRI was not reassessed by an expert neuroradiologist. These factors may influence everyday clinical practice and research into lesional/"non-lesional" epilepsy. As some lesions may be too subtle to appreciate on MRI, even via expert neuroradiological assessment, it is important to develop automated lesion analysis tools, which allow reliable whole-brain quantitative comparison of a Epilepsy protocol: The initial epilepsy protocol at our centre (OC) involved only higher resolution in-plane 2D sequences for patients with presumed seizures (no 3D images). Epilepsy-dedicated research protocol: 2D coronal FLAIR MRI with high in-plane resolution (w0.5 mm), 3D T1W/T2W/T2FLAIR imaging. 3D sequences were reserved for pre-surgical work-up, for instance (1) MRI-negative image with indication of a strong EEG localisation and (2) presumed lesions in patients with MRI-positive findings for further evaluation and characterisation. Technical reasons for previous MRI-negative report are shown in italics. OC, The Walton Centre NHS Foundation Trust; HS, hippocampal sclerosis.
single patient's MRI with those acquired from healthy controls.
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